- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03155152
Decremental Exercise: a New Training Approach?
March 17, 2020 updated by: Swiss Federal Institute of Technology
Decremental Exercise Protocol as a Training Stimulus: More or Less Efficient Than Traditional High-intensity Interval Training?
Different types of high-intensity interval training (HIIT) sessions are used by athletes in order to improve their physical performance, but innovative approaches to training are lacking.
Therefore, in Part A of this study the physiological response to a standard HIIT and a new decremental exercise training (DECT) will be compared in runners and cyclists.
Next, in Part B the training effects of a 4-week block of the HIIT and DECT will be compared.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
55
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
ZH
-
Zurich, ZH, Switzerland, 8057
- Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age: 18-40 years
- Healthy, i.e. normal physical and mental status (not taking any medication on a regular basis for more than a month, except contraceptive medication)
- Normal Body-Mass-Index (BMI): 18.5-24.9 kg·m-2
- Well-trained athletes: V̇O2max > 55.1 ml·min-1·kg-1 for men and > 50.1 ml·min-1·kg-1 for women
- Normal lung function
- Non-smoking
- Willing to adhere to the general study rules
Exclusion Criteria:
- Women who are pregnant or breast feeding
- Intention to become pregnant during the course of the study
- Known or suspected non-compliance, drug or alcohol abuse
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant
- Previous enrolment into the same part (A or B) of the current study
- Enrolment of the investigator, his/her family members, employees and other dependent persons
- Acute or chronic illness
- Intake of medications affecting performance or the respiratory, cardiovascular or neuromuscular system
- Insufficient training history (<3 yrs of participation in competitive cycling/running) or training volume (<40 km running/week or 150 km cycling/week) in the previous 6 months
- Recent (<3 months) history of orthopaedic injury or participation in structured high-intensity training blocks
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: DECT Group
The DECT session consists of four bouts of 4 min high-intensity "decremental" exercise with 3 min of active recovery between bouts.
Load is progressively decreased throughout each exercise bout.
The training period will last for a total of 4 weeks, with three weekly sessions of supervised training
|
The DECT program consists of a 4-week training intervention with three weekly sessions of high-intensity interval training, in which during each exercise bout the workload is imposed in a decremental fashion.
|
Active Comparator: HIIT Group
The HIIT session consists of four bouts of 4 min high-intensity "decremental" exercise with 3 min of active recovery between bouts.
Load is kept constant throughout each exercise bout.
The training period will last for a total of 4 weeks, with three weekly sessions of supervised training
|
The HIIT program consists of a 4-week training intervention with three weekly sessions of high-intensity interval training, in which during each exercise bout the workload is kept constant.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in exercise performance
Time Frame: measured before and after the 4-week training block, during a time-trial (40 km cycling or 10 km running)
|
Time taken to cover a fixed distance, in minutes
|
measured before and after the 4-week training block, during a time-trial (40 km cycling or 10 km running)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in maximal oxygen uptake
Time Frame: Measured during a maximal incremental exercise test before and after the 4-week training block
|
Measured in ml/kg/min
|
Measured during a maximal incremental exercise test before and after the 4-week training block
|
Average oxygen uptake
Time Frame: The two training session are performed within one week
|
Average oxygen uptake measured during the four 4-min bouts of high-intensity exercise of a session of HIIT and DECT
|
The two training session are performed within one week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christina M Spengler, Prof., ETH Zurich
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2017
Primary Completion (Actual)
December 11, 2019
Study Completion (Actual)
December 11, 2019
Study Registration Dates
First Submitted
May 12, 2017
First Submitted That Met QC Criteria
May 15, 2017
First Posted (Actual)
May 16, 2017
Study Record Updates
Last Update Posted (Actual)
March 18, 2020
Last Update Submitted That Met QC Criteria
March 17, 2020
Last Verified
February 1, 2019
More Information
Terms related to this study
Other Study ID Numbers
- DECT_HIIT_2017
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exercise Performance of Fit Athletes
-
Cairo UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisRecruitingParalympic Athletes | Sportive PerformanceFrance
-
Cairo UniversityEnrolling by invitationAthletes | Muscle Performance | TECAR TherapyEgypt
-
University of AgderCompleted
-
University of Nove de JulhoMulti Radiance Medical; São José Rugby ClubCompletedRecovery | Performance | High-level Rugby AthletesBrazil
-
University of Western Ontario, CanadaUnknownEffect of Essential Fatty Acids on Exercise PerformanceCanada
-
Ågot AakraUniversity of Oslo; Norwegian School of Sport Sciences; Norwegian Olympic Sports...UnknownAthletes | Endurance Performance | Microbiota | Iron | Hemoglobin | Intestinal HealthNorway
-
Universidad Autonoma de MadridUniversidad Politecnica de Madrid; Camilo Jose Cela UniversityCompletedNitrates | Nutrition | Physical Performance | Sport Physiology | Elite Athletes
-
Nanyang Technological UniversityRecruitingExercise PerformanceSingapore
-
Morten Hostrup, PhDRecruiting
Clinical Trials on DECT
-
University of UlmUnknownCommunication | EndoscopyGermany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedMalignant Neoplasm | Metastatic Malignant Neoplasm in the BrainUnited States
-
The First Affiliated Hospital with Nanjing Medical...Recruiting
-
M.D. Anderson Cancer CenterRecruitingCarcinoid Tumor | Carcinoid Syndrome | Metastatic Carcinoid Tumor | Digestive System Neuroendocrine Tumor G1United States
-
Duke UniversitySiemens Medical SolutionsTerminatedProstate Cancer | Dual Energy CT (DECT)United States
-
State University of New York - Upstate Medical...Enrolling by invitationOsteoporosisUnited States
-
University of WashingtonCompleted
-
Ardea Biosciences, Inc.Completed
-
Advanced Bionics AGAdvanced BionicsCompletedHearing Loss, Binaural | Hearing Loss, MonauralSwitzerland
-
Lille Catholic UniversityAuckland UniversityRecruiting